Approved & therapeutic

DSIP

Delta Sleep Inducing Peptide

Research compoundEvidence: PreclinicalPeptideLimited human data

A neuropeptide naturally found in the brain that helps regulate sleep cycles. Named for its ability to promote deep, restorative delta-wave sleep.

Also known as: Delta Sleep-Inducing Peptide

Status
DSIP is a research compound and not approved by the FDA for human use.
Evidence
Preclinical. Evidence comes from animal or lab studies; effects in people are not established.
Half-life
~15-25 minutes (effects last through the night)
How it's taken
Subcutaneous injection or intranasal
Mechanism
Other

How DSIP works

Modulates sleep architecture by influencing the ratio of different sleep stages. Promotes delta-wave (deep) sleep, which is when your body does most of its physical repair and memory consolidation.

What research has looked at

Evidence level: Preclinical. Evidence comes from animal or lab studies; effects in people are not established. These are areas studied or reported, not promised effects.

Reported side effects and risks

Sources

  1. PubMed research on delta sleep inducing peptide DSIP · NIH · National Library of Medicine
  2. DrugBank record for delta sleep inducing peptide · DrugBank
  3. StatPearls / NCBI Bookshelf on delta sleep inducing peptide · NCBI Bookshelf

Track DSIP in Peptide Vault

Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.

Get Peptide Vault

Related compounds

DSIP FAQ

What is DSIP?

A neuropeptide naturally found in the brain that helps regulate sleep cycles. Named for its ability to promote deep, restorative delta-wave sleep.

How does DSIP work?

Modulates sleep architecture by influencing the ratio of different sleep stages. Promotes delta-wave (deep) sleep, which is when your body does most of its physical repair and memory consolidation.

Is DSIP FDA approved?

No. DSIP is a research compound and not approved by the FDA for human use. Evidence level: preclinical. Evidence comes from animal or lab studies; effects in people are not established.

What is the half-life of DSIP?

Reported half-life: ~15-25 minutes (effects last through the night).

How is DSIP taken?

Subcutaneous injection or intranasal.

What side effects have been reported with DSIP?

Reported in the sources: Morning grogginess; Mild headache; Low blood pressure in some users; Limited clinical trial data; Not FDA-approved.

Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.